Citadel Advisors’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.41M Sell
62,500
-16,000
-20% -$665K ﹤0.01% 5698
2025
Q4
$3.65M Sell
78,500
-139,300
-64% -$6.71M ﹤0.01% 4813
2025
Q3
$10.7M Buy
217,800
+145,300
+200% +$7.6M ﹤0.01% 3172
2025
Q2
$3.75M Buy
+72,500
New +$2.93M ﹤0.01% 4604

Other funds holding HNGE

Citadel Advisors's HNGE Position: Q1 2026 in Review

Citadel Advisors increased its Hinge Health (HNGE) stake by 114% in Q1 2026, buying an estimated $24M and bringing the position to 1,083,715 shares worth $41.8M. The position accounts for 0.01% of the portfolio, ranked #1528.

Citadel Advisors first reported a position in HNGE in Q2 2025 and has held it in 4 quarters since. 203 funds tracked by Wall St. Rank hold HNGE as of Q1 2026.

  • Citadel Advisors held 1,083,715 shares of Hinge Health worth $41.8M as of Q1 2026.
  • Citadel Advisors bought 577,611 Hinge Health shares in Q1 2026, an estimated $24M.
  • Hinge Health made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1528 holding.
  • Citadel Advisors first reported a position in Hinge Health in Q2 2025 and has held it in 4 quarters since.
  • 203 funds tracked by Wall St. Rank held Hinge Health as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.